# AURITEC PHARMACEUTICALS, INC.: Long-acting Injectable Brexpiprazole for Agitation in Alzheimer's Dementia

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | AURITEC PHARMACEUTICALS, INC. |
| Location | PASADENA, CA |
| Project | Long-acting Injectable Brexpiprazole for Agitation in Alzheimer's Dementia |
| Project number | 1R44AG102256-01 |
| Mechanism | R44 |
| Institute | National Institute on Aging |
| Award | $1,029,519 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-22 to 2028-05-31 |
| UEI | QX8KP6JKQ2L8 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11410220). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.